A Scoping Review and Meta-Analysis of Anti-CGRP Monoclonal Antibodies: Predicting Response by Ja Bin Hong, Kristin Sophie Lange, Lucas Hendrik Overeem, Paul Triller, Bianca Raffaelli, Uwe Reuter

Get full text

Impact of a reimbursement policy change on treatment with erenumab in migraine – a real-world experience from Germany by Ja Bin Hong, Kristin Sophie Lange, Mira Fitzek, Lucas Hendrik Overeem, Paul Triller, Anke Siebert, Uwe Reuter, Bianca Raffaelli

Get full text

Change of CGRP Plasma Concentrations in Migraine after Discontinuation of CGRP-(Receptor) Monoclonal Antibodies by Bianca Raffaelli, Maria Terhart, Mira Pauline Fitzek, Kristin Sophie Lange, Jasper Mecklenburg, Lucas Hendrik Overeem, Anke Siebert, Elisabeth Storch, Uwe Reuter

Get full text

Effect of switching to erenumab in non-responders to a CGRP ligand antibody treatment in migraine: A real-world cohort study by Lucas Hendrik Overeem, Lucas Hendrik Overeem, Kristin Sophie Lange, Mira Pauline Fitzek, Anke Siebert, Maureen Steinicke, Paul Triller, Ja Bin Hong, Uwe Reuter, Uwe Reuter, Bianca Raffaelli, Bianca Raffaelli

Get full text

Genetics of migraine: where are we now? by Lou Grangeon, Kristin Sophie Lange, Marta Waliszewska-Prosół, Dilara Onan, Karol Marschollek, Wietse Wiels, Petr Mikulenka, Fatemeh Farham, Cédric Gollion, Anne Ducros, on behalf of the European Headache Federation School of Advanced Studies (EHF-SAS)

Get full text